Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG. Long GD, et al. Among authors: blume kg. Biol Blood Marrow Transplant. 1997 Dec;3(6):324-30. Biol Blood Marrow Transplant. 1997. PMID: 9502300 Clinical Trial.
Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma.
Liso A, Stockerl-Goldstein KE, Auffermann-Gretzinger S, Benike CJ, Reichardt V, van Beckhoven A, Rajapaksa R, Engleman EG, Blume KG, Levy R. Liso A, et al. Among authors: blume kg. Biol Blood Marrow Transplant. 2000;6(6):621-7. doi: 10.1016/s1083-8791(00)70027-9. Biol Blood Marrow Transplant. 2000. PMID: 11128812 Free article. Clinical Trial.
High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience.
Cao TM, Horning S, Negrin RS, Hu WW, Johnston LJ, Taylor TL, Shizuru JA, Hoppe RT, Brown BW, Blume KG, Stockerl-Goldstein KE. Cao TM, et al. Among authors: blume kg. Biol Blood Marrow Transplant. 2001;7(5):294-301. doi: 10.1053/bbmt.2001.v7.pm11400952. Biol Blood Marrow Transplant. 2001. PMID: 11400952 Free article.
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R. Maloney DG, et al. Among authors: blume kg. Blood. 2003 Nov 1;102(9):3447-54. doi: 10.1182/blood-2002-09-2955. Epub 2003 Jul 10. Blood. 2003. PMID: 12855572 Free article. Clinical Trial.
Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease.
Johnston LJ, Brown J, Shizuru JA, Stockerl-Goldstein KE, Stuart MJ, Blume KG, Negrin RS, Chao NJ. Johnston LJ, et al. Among authors: blume kg. Biol Blood Marrow Transplant. 2005 Jan;11(1):47-55. doi: 10.1016/j.bbmt.2004.10.004. Biol Blood Marrow Transplant. 2005. PMID: 15625544 Free article. Clinical Trial.
285 results